Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

Share Price Information for Centaur (CAU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 39.00
Ask: 41.00
Change: 0.50 (1.27%)
Spread: 2.00 (5.128%)
Open: 39.50
High: 40.00
Low: 39.50
Prev. Close: 39.50
CAU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendment to previous Form 8

22 Apr 2024 18:25

RNS Number : 5723L
Centaur Media PLC
22 April 2024
 

Amendment to previous Form 8 (OPD)

please see Section 3 Centaur Deferred Share Bonus Plan for amended details

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Centaur Media plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Centaur Media plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

18 April 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

10p Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

0

0

(2) Cash-settled derivatives:

 

0

0

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0

 

TOTAL:

0

0

0

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Ordinary shares held by the directors of Centaur Media plc ("Centaur"), their close relatives and related trusts:

 

Person

 

Number of Centaur shares

 

% of Centaur issued share capital (excluding treasury shares)

Colin Jones*

266,235

0.18%

Simon Longfield*

349,785

0.23%

Rina Mukerji**

621,582

0.42%

Swagatam Mukerji*

553,655

0.37%

TOTAL

1,791,257

 

1.22%

* Director of Centaur

** Close relative of director of Centaur

 

(b) Options and awards granted under Centaur's share plans held by the directors of Centaur

 

Centaur Long Term Incentive Plan:

 

Centaur director

 

Number of Centaur shares awarded*

 

Date of award

 

Date (expected) of vesting

 

Exercise period and price (£) **

2021 LTIP awards

Simon Longfield

451,898

25 March 2021

25 March 2024

6 months / £0.00

Swagatam Mukerji

826,329

25 March 2021

25 March 2024

6 months / £0.00

2022 LTIP awards

Simon Longfield

416,667

24 March 2022

24 March 2025

6 months / £0.00

Swagatam Mukerji

700,417

24 March 2022

24 March 2025

6 months / £0.00

2023 LTIP awards

Simon Longfield

408,163

12 April 2023

12 April 2026

6 months / £0.00

Swagatam Mukerji

686,122

12 April 2023

12 April 2026

6 months / £0.00

TOTAL LTIP AWARDS OUTSTANDING

Simon Longfield

 

1,276,728

Swagatam Mukerji

2,212,868

 

* Under the Centaur LTIP, a maximum number of Centaur shares are granted on the date of grant and which vest in accordance with performance conditions as further set out in Centaur's annual report for the financial year ended 31 December 2023.

** In addition to an exercise period of 6 months, each award is subject to a holding period of 2 years from the date of vesting during which a participant will not sell or otherwise transfer or dispose of any of their vested shares under such award.

 

Centaur Deferred Share Bonus Plan:

 

Centaur director

 

Number of Centaur shares awarded*

 

Date of award

 

Date (expected) of vesting

 

Exercise period and price (£) **

Simon Longfield

21,421

12 May 2022

24 March 2025

6 months / £0.00

Swagatam Mukerji

39,172

12 May 2022

24 March 2025

6 months / £0.00

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

19 April 2024

Contact name:

Simon Longfield, CFO

Telephone number:

+44 (0) 20 7970 4000

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEQLLFLZZLBBBL
Date   Source Headline
20th Feb 202410:49 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSDirector/PDMR Shareholding
18th Jan 20247:00 amRNSTrading Update
19th Dec 202311:25 amRNSDirector/PDMR Shareholding
20th Nov 202311:22 amRNSDirector/PDMR Shareholding
26th Oct 20234:44 pmRNSDirector/PDMR Shareholding
22nd Sep 20239:30 amRNSDirector/PDMR Shareholding
20th Sep 20232:51 pmRNSDirector/PDMR Shareholding
19th Sep 202311:22 amRNSDirector/PDMR Shareholding
25th Aug 202311:00 amRNSDirector/PDMR Shareholding
21st Aug 202310:40 amRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSInterim Results
17th Jul 20233:43 pmRNSDirector/PDMR Shareholding
21st Jun 20233:28 pmRNSDirector/PDMR Shareholding
1st Jun 202311:18 amRNSDirector Declaration
31st May 20234:35 pmRNSDirector Declaration
18th May 202311:44 amRNSDirector/PDMR Shareholding
10th May 20233:33 pmRNSResult of AGM
18th Apr 202311:47 amRNSDirector/PDMR Shareholding
12th Apr 20232:41 pmRNSDirector/PDMR Shareholding
4th Apr 20231:48 pmRNSAnnual Financial Report
21st Mar 20239:51 amRNSHolding(s) in Company
20th Mar 20233:33 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
20th Feb 20239:30 amRNSDirector/PDMR Shareholding
31st Jan 20239:01 amRNSHolding(s) in Company
23rd Jan 20239:25 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update & Declaration of a Special Dividend
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20222:19 pmRNSDirector/PDMR Shareholding
22nd Nov 20221:52 pmRNSDirector/PDMR Shareholding
16th Nov 20223:57 pmRNSDirector/PDMR Shareholding
24th Oct 20229:37 amRNSDirector/PDMR Shareholding
23rd Sep 202211:24 amRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 20225:13 pmRNSDirector/PDMR Shareholding
25th Jul 20229:50 amRNSDirector/PDMR Shareholding
20th Jul 20227:00 amRNSInterim Results
5th Jul 202210:30 amRNSDirector/PDMR Shareholding
23rd May 202210:33 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSNon-Executive Director Appointment
12th May 202211:08 amRNSDirector/PDMR Shareholding
11th May 20223:09 pmRNSResult of AGM
21st Apr 202211:27 amRNSDirector/PDMR Shareholding
1st Apr 202211:54 amRNSAnnual Financial Report
25th Mar 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20223:24 pmRNSDirector/PDMR Shareholding
18th Mar 20229:35 amRNSDirector/PDMR Shareholding
18th Mar 20229:31 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.